Secondary end-users: no health problem, rehabilitation experts such as physiotherapists and sports scientists working at rehabilitation centres, geriatric institutions etc. Tertiary end-users: no health problem, employees in managerial positions at public healthcare payers (for example, health insurance companies), as well as other health care facilities I69 R26 G20 G21 G35 G81 G82 I61 I63
Conditions
Interventions
Group 1: Focus group investigation in primary end-users (older people who are aged 65 or over and at risk of falls), as well as in secondary end-users (physiotherapists and sports scientists who work
Sponsors
VASCage GmbH Research Centre on Vascular Ageing and Stroke (für österr. Partner)
Eligibility
Sex/Gender
All
Age
65 Years to 99 Years
Inclusion criteria
Inclusion criteria: Primary end-user group: older adults (geriatric population defined by the presence of a geriatric-typical multi-morbidity and an older age) at the risk of falling – (1) aged 65 years or older, (2) cognitive status allowing them to understand the study procedure/content and informed consent, (3) able to walk with or without a supportive device for 10 metres or are able, if wheelchair- dependent, to sit in a wheelchair without arm- and back rests. Secondary end-user group: healthcare providers working at health care services/institutions, e.g., rehabilitation centers, geriatric institutions/organisations e.g., physiotherapists or sports scientists. Tertiary end-user group: employees in managerial positions working at health insurers or public sector service organisers
Exclusion criteria
Exclusion criteria: Impaired cognition that disables consenting in participation; vision defect, inability to read, recognise pictures; severe comorbidities (such as severe psychiatric or neurological diseases) or terminal illness that interfere with the study participation; influence of medication which may impair cognition (e.g., morphine, neuroleptics, benzodiazepine). Older adults will be excluded if they present with a joint contracture (shoulder, knee, hip), psychiatric diseases, have a terminal illness with a prognosis of less than 12 months or intense pain during movements (> 5 on the Visual Analogue Scale)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Insider in-depth-knowledge about primary and secondary end-users’ needs, opinions, preferences, fears and experiences of an ExerG training as a basis for the ExerG concept and corresponding hardware and software extensions. Outcome measurement: focus group investigation (primary and secondary end-users); additional collection of demographic (age, gender) and disease-specific (e.g., type of disease/diagnosis, disease duration and severity; primary end-users) or profession-specific data (e.g., profession, highest degree, work experience; secondary end-users). | — |
Secondary
| Measure | Time frame |
|---|---|
| Insider in-depth knowledge about tertiary end-users’ opinions, preferences and experiences of an ExerG training as a basis for the ExerG concept and corresponding hardware and software extensions. Outcome measurement: semi-structured interviews; additional collection of demographic (age, gender) and profession-specific data (e.g., profession, highest degree, work experience). | — |
Countries
Austria, Canada, Switzerland
Contacts
Public ContactBarbara Seebacher
Reha Zentrum Münster
Outcome results
None listed